NO910267L - Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstilling - Google Patents
Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstillingInfo
- Publication number
- NO910267L NO910267L NO91910267A NO910267A NO910267L NO 910267 L NO910267 L NO 910267L NO 91910267 A NO91910267 A NO 91910267A NO 910267 A NO910267 A NO 910267A NO 910267 L NO910267 L NO 910267L
- Authority
- NO
- Norway
- Prior art keywords
- crystallinic
- hydrochloride
- procedure
- preparation
- lactam antibiotics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47048690A | 1990-01-26 | 1990-01-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO910267D0 NO910267D0 (no) | 1991-01-23 |
| NO910267L true NO910267L (no) | 1991-07-29 |
Family
ID=23867812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91910267A NO910267L (no) | 1990-01-26 | 1991-01-23 | Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstilling |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0439353B1 (no) |
| JP (1) | JPH04234880A (no) |
| KR (1) | KR910014378A (no) |
| CN (1) | CN1053611A (no) |
| AU (1) | AU631960B2 (no) |
| CA (1) | CA2034592C (no) |
| DE (1) | DE69118933T2 (no) |
| ES (1) | ES2087240T3 (no) |
| FI (1) | FI910365A (no) |
| HU (1) | HU208972B (no) |
| IE (1) | IE910251A1 (no) |
| IL (1) | IL96979A0 (no) |
| MX (1) | MX24247A (no) |
| NO (1) | NO910267L (no) |
| NZ (1) | NZ236868A (no) |
| PT (1) | PT96531A (no) |
| RU (1) | RU1825365C (no) |
| YU (1) | YU12191A (no) |
| ZA (1) | ZA91428B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| AU1234999A (en) * | 1997-11-10 | 1999-05-31 | Gist-Brocades B.V. | Crystallization of beta-lactam compounds |
| WO2004046142A1 (en) * | 2002-11-21 | 2004-06-03 | Ranbaxy Laboratories Limited | Monohydrate solvates of loracarbef |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
| EG18529A (en) * | 1987-10-06 | 1993-04-30 | Lilly Co Eli | Process for preparing b-lactam hydrate |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
-
1991
- 1991-01-18 CA CA002034592A patent/CA2034592C/en not_active Expired - Fee Related
- 1991-01-20 IL IL96979A patent/IL96979A0/xx unknown
- 1991-01-21 PT PT96531A patent/PT96531A/pt not_active Application Discontinuation
- 1991-01-21 ZA ZA91428A patent/ZA91428B/xx unknown
- 1991-01-23 NO NO91910267A patent/NO910267L/no unknown
- 1991-01-23 KR KR1019910001115A patent/KR910014378A/ko not_active Application Discontinuation
- 1991-01-23 AU AU69923/91A patent/AU631960B2/en not_active Ceased
- 1991-01-23 NZ NZ236868A patent/NZ236868A/en unknown
- 1991-01-23 MX MX2424791A patent/MX24247A/es unknown
- 1991-01-24 CN CN91100511A patent/CN1053611A/zh active Pending
- 1991-01-24 EP EP91300539A patent/EP0439353B1/en not_active Expired - Lifetime
- 1991-01-24 FI FI910365A patent/FI910365A/fi not_active Application Discontinuation
- 1991-01-24 JP JP3041442A patent/JPH04234880A/ja active Pending
- 1991-01-24 IE IE025191A patent/IE910251A1/en unknown
- 1991-01-24 HU HU91263A patent/HU208972B/hu not_active IP Right Cessation
- 1991-01-24 DE DE69118933T patent/DE69118933T2/de not_active Expired - Fee Related
- 1991-01-24 YU YU12191A patent/YU12191A/sh unknown
- 1991-01-24 RU SU914894298A patent/RU1825365C/ru active
- 1991-01-24 ES ES91300539T patent/ES2087240T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU6992391A (en) | 1991-08-01 |
| DE69118933T2 (de) | 1996-10-02 |
| AU631960B2 (en) | 1992-12-10 |
| ES2087240T3 (es) | 1996-07-16 |
| FI910365A (fi) | 1991-07-27 |
| KR910014378A (ko) | 1991-08-31 |
| EP0439353A1 (en) | 1991-07-31 |
| NO910267D0 (no) | 1991-01-23 |
| ZA91428B (en) | 1992-09-30 |
| CA2034592C (en) | 2001-06-05 |
| HU910263D0 (en) | 1991-08-28 |
| RU1825365C (ru) | 1993-06-30 |
| PT96531A (pt) | 1991-10-15 |
| MX24247A (es) | 1993-11-01 |
| YU12191A (sh) | 1994-01-20 |
| DE69118933D1 (de) | 1996-05-30 |
| HUT57207A (en) | 1991-11-28 |
| FI910365A0 (fi) | 1991-01-24 |
| IL96979A0 (en) | 1992-03-29 |
| IE910251A1 (en) | 1991-07-31 |
| CA2034592A1 (en) | 1991-07-27 |
| JPH04234880A (ja) | 1992-08-24 |
| CN1053611A (zh) | 1991-08-07 |
| HU208972B (en) | 1994-02-28 |
| EP0439353B1 (en) | 1996-04-24 |
| NZ236868A (en) | 1992-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8847962A0 (it) | Composizioni farmaceutiche contenenenti cefuroxima axetil e procedimento per prepararle | |
| NO902156D0 (no) | Terapeutisk anvendbar oxadiazolforbindelse og fremgangsmaate for dens fremstilling. | |
| NO921976L (no) | Amidestere av rapamycin | |
| NO171979C (no) | Analogifremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater | |
| NO914027L (no) | Fremgangsmaate for fremstilling av nye substituerte azetidinoner | |
| NO175873C (no) | Mikrobiell fremgangsmåte for fremstilling av immunhemmende antibiotika | |
| NO912344L (no) | Fremgangsmaate for fremstilling av benzopyranderivater og heterocykliske derivater derav | |
| LV10255B (en) | N-substituted heterocyclic compounds, method of preparation thereof and pharmaceutical composition comprising thereof | |
| NO940027D0 (no) | Fremgangsmaate for fremstilling av derivater av _fenylisoserin og derivatenes anvendelse | |
| NO845005L (no) | Fremgangsmaate for fremstilling av antibiotikum l 17392 (deglukoteicoplanin) og salter derav | |
| NO914233D0 (no) | Fremgangsmaate for fremstilling av muramyldipeptidderivater og influensavaksine som omfatter derivatene | |
| NO994505L (no) | Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner | |
| NO885295L (no) | Krystaller av cefemhydroklorid. | |
| NO910267L (no) | Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstilling | |
| ZA891442B (en) | Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion | |
| NO932129D0 (no) | Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater | |
| EP0420069A3 (en) | Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics | |
| ZA893483B (en) | Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics | |
| NO903386L (no) | Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-karbamater og -tiokarbamater og derivater derav. | |
| HU9202064D0 (en) | Heterocyclic compounds of renine-inhibiting effect and method for production and application of these compounds | |
| NO942531D0 (no) | Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener | |
| NO914577D0 (no) | Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser | |
| IS3795A7 (is) | Cephalosporinafleiður og aðferð til framleiðslu þeirra | |
| NO910135D0 (no) | Fremgangsmaate for fremstilling og anvendelse av et nytt antibiotikum alisamycin. | |
| NO931978D0 (no) | Amider av antibiotiske ge 2270 faktorer |